Tocilizumab for the treatment of non‐critical COVID‐19 pneumonia: an overview of the rationale and clinical evidence to date
Author:
Affiliation:
1. Centre for Experimental Pathogen Host Research, School of Medicine, University College Dublin, Dublin, Ireland
2. Infectious Diseases Department, St Vincent’s University Hospital, Dublin, Ireland
Publisher
Informa UK Limited
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/17512433.2021.1949286
Reference52 articles.
1. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
2. Interleukin-6: from an inflammatory marker to a target for inflammatory diseases
3. Schneider C, Borvendég J Assessment report For RoActemra. Eur Med Agency. 2009;1–66.
4. Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
5. Targeting Interleukin-6 Signaling in Clinic
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Early inflammatory profiles predict maximal disease severity in COVID-19: An unsupervised cluster analysis;Heliyon;2024-08
2. Early Tocilizumab Administration was Associated with Decreased Mortality in COVID-19 Hospitalized Patients;2023-11-08
3. Assessment of drugs administered in the Middle East as part of the COVID-19 management protocols;Inflammopharmacology;2022-08-26
4. Current status and prospects of IL-6–targeting therapy;Expert Review of Clinical Pharmacology;2022-05-04
5. Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3